Outcomes Research in the Treatment of Asthma

Outcomes Research in the Treatment of Asthma

Ram C. Neupane (College of Georgia, USA) and Jason Turner (University of Louisville, USA)
DOI: 10.4018/978-1-61520-723-7.ch004
OnDemand PDF Download:
$37.50

Abstract

Asthma is a common chronic disease in the United States, with increasing prevalence. Many patients do not realize therapeutic goals because of poor disease management. The purpose of this study is to examine the costs of the commonly used drugs used to treat asthma. We examined the contribution of individual, government and private agencies for medication payment. We next compared the prescription cost to the cost of emergency room visits. The data are taken from the Medical Expenditure Panel Survey. SAS Enterprise Guide was used for preprocessing and data visualization. It was found that prednisone is the cheapest drug and the drug, albuterol, is the most common, even if it is more expensive. The contribution of the government is higher than the amount paid by individuals and other agencies. We examined data from the National Inpatient Sample to investigate trends in asthma as well.

Complete Chapter List

Search this Book:
Reset